Clot lysis time and thrombin generation in patients undergoing transcatheter aortic valve implantation

Aleksander Siniarski1,2, Aleksandra Gąsecka3, Katarzyna Krysińska4

  • 1Department of Coronary Artery Disease and Heart Failure, Faculty of Medicine, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.

Insights

Transcatheter aortic valve implantation (TAVI) improved coagulation profiles in severe aortic stenosis (AS) patients by reducing clot lysis time (CLT) and peak thrombin generation. Baseline CLT and C-reactive protein (CRP) predicted successful TAVI outcomes.

Area of Science:

  • Cardiology
  • Hematology
  • Biochemistry

Background:

  • Severe aortic stenosis (AS) is a prevalent valvular heart disease linked to mortality and coagulation abnormalities, including fibrin deposition.
  • Transcatheter aortic valve implantation (TAVI) is a key treatment for high-risk AS patients.

Purpose of the Study:

  • To evaluate the effect of TAVI on thrombin generation and clot lysis time (CLT) in severe AS patients.

Main Methods:

  • Assessed 135 symptomatic AS patients before and after TAVI.
  • Measured clot lysis time (CLT), lag time, peak thrombin generation, time to peak thrombin generation (ttPeak), and endogenous thrombin potential (ETP).
  • Utilized clinical assessment, echocardiography, and multivariable linear regression analysis.

Main Results:

  • TAVI significantly reduced CLT by 9% and peak thrombin concentration by 13%.
  • Observed significant increases in lag time (20%) and ttPeak (12%) post-TAVI.
  • Baseline CLT and C-reactive protein (CRP) levels independently predicted successful TAVI, defined by reduced mean aortic gradient.

Conclusions:

  • TAVI positively impacts coagulation, decreasing CLT and peak thrombin generation while increasing lag time and ttPeak.
  • CLT and CRP are crucial predictors of TAVI procedural success.
Abstract

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.1K
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.8K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.5K